Catapult Capital Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$4.93M Buy
225,000
+15,000
+7% +$375K 1.86% 10
2015
Q2
$5.17M Sell
210,000
-15,000
-7% -$335K 0.74% 33
2015
Q1
$4.61M Buy
225,000
+50,000
+29% +$969K 0.56% 56
2014
Q4
$3.49M Buy
175,000
+115,000
+192% +$1.97M 0.89% 30
2014
Q3
$883K Sell
60,000
-25,000
-29% -$398K 0.09% 157
2014
Q2
$1.56M Sell
85,000
-130,000
-60% -$2.16M 0.18% 144
2014
Q1
$4.04M Sell
215,000
-30
-0% -$615 0.81% 35
2013
Q4
$4.02M Buy
215,030
+50,000
+30% +$727K 0.96% 30
2013
Q3
$1.81M Hold
165,030
0.22% 140
2013
Q2
$1.57M Buy
+165,030
New +$1.44M 0.65% 46

Other funds holding ATRC

Catapult Capital Management's ATRC Position: Q3 2015 in Review

Catapult Capital Management increased its AtriCure (ATRC) stake by 7.1% in Q3 2015, buying an estimated $375K and bringing the position to 225,000 shares worth $4.93M. The position accounts for 1.86% of the portfolio, ranked #10.

Catapult Capital Management first reported a position in ATRC in Q2 2013 and has held it in 10 quarters since. The position peaked at $5.17M in Q2 2015. 121 funds tracked by Wall St. Rank hold ATRC as of Q3 2015.

  • Catapult Capital Management held 225,000 shares of AtriCure worth $4.93M as of Q3 2015.
  • Catapult Capital Management bought 15,000 AtriCure shares in Q3 2015, an estimated $375K.
  • AtriCure made up 1.86% of Catapult Capital Management's portfolio in Q3 2015, its #10 holding.
  • Catapult Capital Management first reported a position in AtriCure in Q2 2013 and has held it in 10 quarters since.
  • Catapult Capital Management's AtriCure position peaked at $5.17M in Q2 2015.
  • 121 funds tracked by Wall St. Rank held AtriCure as of Q3 2015.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.